The AI in Clinical Trials Market was valued USD 1.59 Billion in 2023 and projected to reach USD 6.55 Billion by 2030, growing at a CAGR of 22.4 % during.
The global AI-based clinical trials solution market providers is expected to grow at a compound annual growth rate (CAGR) of 23.2% between 2022 and 2032, from US$ 1.7 billion in 2022 to US$ 14.2 billion.Future Market Insights, a market research, and competitive intelligence provider, analyses that AI-based Clinical.
As per the report by Visiongain, the AI-based Clinical Trial Solution Providers Market was valued at US$1,232.0 million in 2022 and is projected to grow at.
Experts and company leadership to discuss clinical significance of indications driven by muscle atrophy and Ph2 trial design for acute ICU myopathies in older patientsRICHMOND, Calif. (BUSINESS WIRE) #aging BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target th.